Related by context. All words. (Click for frequent words.) 77 Erlotinib 76 Bevacizumab 76 Dasatinib 76 Nilotinib 75 Fludarabine 75 Peginterferon 75 Pemetrexed 75 Bortezomib 74 Fulvestrant 74 Vidaza azacitidine 74 PEGylated Fab fragment 74 metastatic malignant 74 Trastuzumab 74 Natalizumab 74 Posaconazole 73 Paraplatin ® 73 generation purine nucleoside 73 Torisel 73 Gemcitabine 73 Patients Treated With 73 Capecitabine 73 Temsirolimus 73 Melphalan 73 sorafenib Nexavar 73 refractory chronic lymphocytic 73 Oxaliplatin 73 Platinol ® 73 Monotherapy 73 Tacrolimus 73 Antitumor Activity 72 thalidomide Thalomid 72 TNF Tumor Necrosis Factor 72 gemcitabine Gemzar 72 DOXIL 72 Bosutinib 72 erlotinib Tarceva ® 72 Peginterferon alfa 2b 72 Neoadjuvant 72 gefitinib Iressa 72 mTOR inhibitor 72 Epratuzumab 72 Ranolazine 72 Irinotecan 72 Voreloxin 72 Nucleoside 72 Azacitidine 72 Mitoxantrone 72 GW# [003] 72 Meets Primary Endpoint 72 Mycophenolate Mofetil 72 Interferon beta 1a 72 azacitidine 72 trabectedin 72 Pharmacokinetics PK 72 Adjuvant Therapy 72 pegylated liposomal doxorubicin 72 Pegylated Liposomal Doxorubicin 72 Etanercept 71 Medoxomil 71 Gefitinib 71 boosted protease inhibitor 71 Moxifloxacin 71 Interferon alfa 71 Adjuvant Treatment 71 Cilostazol 71 Aliskiren 71 adalimumab Humira 71 Docetaxel 71 Prolongs Survival 71 Chemoradiation 71 Romiplostim 71 mycophenolate mofetil 71 demethylating agent 71 Complicated Skin 71 Degarelix 71 Candesartan 71 Glatiramer Acetate 71 Relapsed Refractory 71 cetuximab Erbitux ® 71 tocilizumab 71 Fingolimod 71 Fondaparinux 71 Cyclooxygenase 2 71 Azathioprine 71 XYOTAX TM 71 Pertuzumab 71 Tocilizumab 71 Fluconazole 71 Decitabine 71 Lubiprostone 71 Pegylated 71 Fludara ® 71 xanthine oxidase inhibitor 71 metastatic renal cell carcinoma 71 Alemtuzumab 71 Cyclophosphamide 71 Oral Fingolimod 71 pan HDAC inhibitor 71 Camptosar ® 71 Maribavir 71 PEGylated anti 70 Gemzar ® 70 Xeloda ® 70 angiotensin II receptor blocker 70 Dabigatran 70 Drug Candidate 70 Eltrombopag 70 alefacept 70 Taxol ® 70 Topotecan 70 sorafenib tablets 70 ritonavir boosted 70 Xanafide 70 dasatinib Sprycel ® 70 AVASTIN 70 Hycamtin 70 Antiviral Therapy 70 decitabine 70 Study Evaluating 70 Disease Progression 70 Peginterferon Alfa 2a 70 ® lenalidomide 70 FASLODEX 70 Unfractionated Heparin 70 Abacavir 70 Liposomal 70 gemcitabine carboplatin 70 Anastrozole 70 interferon gamma 1b 70 Anti TNF 70 beta 1a 70 sunitinib malate 70 Cutaneous T 70 Previously Treated 70 Vandetanib 70 Adjuvant Chemotherapy 70 Copegus ribavirin 70 cetuximab Erbitux R 70 aspirin clopidogrel 70 Combination Therapy 70 PEG IFN 70 Naive Patients 70 Amrubicin 70 FOLFOX6 70 Pazopanib 70 Treated Patients 70 Ixabepilone 70 Orally Active 70 Sorafenib 70 dasatinib Sprycel 70 oxaliplatin Eloxatin 70 Hsp# Inhibitor 70 imatinib Gleevec ® 70 ZOLINZA 70 Taxotere ® 70 Hycamtin ® 70 docetaxel Taxotere ® 70 Vidaza ® 70 liposomal formulation 70 nucleoside analog 70 Darunavir 70 Novel Oral 70 Aptivus ® 70 Telmisartan 70 vapreotide acetate 70 ara C 70 receptor tyrosine kinase inhibitor 70 bevacizumab Avastin 70 cinacalcet 70 Doxil ® 70 Ranibizumab 70 Orally administered 70 Pegylated Interferon 70 Aflibercept 70 Epirubicin 70 Tigecycline 70 Hormone Refractory Prostate Cancer 70 MAGE A3 ASCI 70 bevacizumab Avastin R 70 Vidaza R 70 selective modulator 70 efalizumab 70 FOLFIRI 70 Temozolomide 70 Everolimus 70 Previously Untreated 70 Bivalirudin 70 Bucindolol 70 RoACTEMRA 70 paclitaxel Taxol 70 TAXOTERE R 70 Ambrisentan 69 Patients Treated 69 PKC# 69 alfa 2a 69 5 FU leucovorin 69 Rituximab 69 fluoropyrimidine 69 Renal Cell Carcinoma 69 Demonstrates Significant 69 Bosentan 69 Zorbtive TM 69 evaluating tivozanib 69 Nexavar sorafenib 69 vinca alkaloid 69 Pioglitazone 69 SPRYCEL ® 69 gastrointestinal stromal tumors GIST 69 Teriparatide 69 Anti Tumor Activity 69 abacavir lamivudine 69 TEMODAL 69 Soft Tissue Sarcoma 69 biologic therapy 69 etanercept Enbrel 69 Lamotrigine 69 Sanofi Aventis Taxotere 69 Mg Usa 69 Gleevec imatinib mesylate 69 EGFR TKI 69 Herceptin trastuzumab 69 Is Well Tolerated 69 TO AVOID PREGNANCY WHILE 69 Tesamorelin 69 gemcitabine Gemzar ® 69 Valsartan 69 Trabectedin 69 Infliximab 69 Cyclosporine 69 IIIa inhibitor 69 Gleevec resistant 69 Adefovir 69 YONDELIS 69 Carvedilol 69 erlotinib Tarceva 69 Glufosfamide 69 Granted Orphan Drug 69 PEG interferon 69 Estrogen Receptor 69 Fluorouracil 69 Plaque Psoriasis 69 vorinostat 69 Tumor Necrosis Factor 69 Allogeneic 69 Exemestane 69 ADP receptor antagonist 69 Traficet EN 69 LymphoStat B belimumab 69 myelodysplastic myeloproliferative diseases 69 tenofovir emtricitabine 69 Pirfenidone 69 fluvastatin 69 5FU 69 Chemokine Receptor 69 Ticagrelor 69 Improved Survival 69 biologic DMARD 69 pharmacologically active isomer 69 chronic eosinophilic leukemia 69 mRCC 69 sunitinib Sutent ® 69 Navelbine ® 69 Long Term Efficacy 69 selective antagonist 69 angiotensin receptor blocker ARB 69 Cetuximab 69 developing Bicifadine serotonin 69 Interferon Alfa 69 infusional 5-FU/LV 69 pegylated interferons 69 Well Tolerated 69 Platinol ® cisplatin 69 Leukine ® 69 melphalan prednisone 69 Safinamide 69 Enoxaparin 69 5 fluorouracil leucovorin 69 HMG CoA reductase inhibitors 69 Investigational Treatment 69 induced macular edema 69 Clofarabine 69 Cloretazine 69 Pooled Analysis 69 Chronic Hepatitis C 69 Yondelis ® 69 Fluticasone 69 Velcade bortezomib 69 metformin sulfonylurea 69 Interferon beta 69 NAVISTAR R 69 calcineurin inhibitors 69 antiplatelet agent 69 Omalizumab 69 Cloretazine VNP#M 69 Denufosol 69 Mg Uk 69 metaglidasen 69 bortezomib Velcade 69 Clolar ® 69 LHRH receptor positive 69 temsirolimus 68 candesartan cilexetil 68 Abatacept 68 Immunosuppression 68 Dapagliflozin 68 Adalimumab 68 TYKERB 68 tyrosine kinase inhibitor 68 Interferon Alpha 68 5 Fluorouracil 68 Lupus Nephritis 68 Prospective Randomized 68 Alkeran 68 Recombinant Human 68 Nitazoxanide 68 Mimpara 68 dual endothelin receptor antagonist 68 Anthracycline 68 ACE Inhibitor 68 Diffuse Large B 68 Peg IFN 68 vandetanib 68 multikinase inhibitor 68 K ras mutations 68 Boceprevir 68 hypereosinophilic syndrome 68 ACE Inhibitors 68 Metastatic Colorectal Cancer 68 abacavir Ziagen 68 posaconazole 68 Zarnestra 68 ixabepilone 68 icatibant 68 Tiotropium 68 Noxafil 68 Vinorelbine 68 corticosteroid dexamethasone 68 Acute Ischemic Stroke 68 paclitaxel Taxol ® 68 R lenalidomide 68 INTEGRILIN R 68 Granulocyte Colony Stimulating Factor 68 Aurora Kinase 68 sunitinib Sutent 68 Hydrochlorothiazide 68 biliary tract cancer 68 Receives Orphan Drug Designation 68 pioglitazone HCl 68 COPEGUS R 68 Roche Actemra 68 denileukin diftitox 68 Improves Survival 68 Losartan 68 chemotherapy cisplatin 68 Advanced Renal Cell 68 IMiDs ® 68 cell lymphoma CTCL 68 Castration Resistant Prostate Cancer 68 MabCampath 68 Taxol paclitaxel 68 PegIntron 68 Calcitonin 68 IRESSA 68 Vidofludimus 68 MGd 68 Tipranavir 68 Ixempra 68 Severe Sepsis 68 luteinizing hormone releasing 68 Leucovorin 68 bevacizumab Avastin ® 68 somatostatin analogue 68 Initiate Clinical Trial 68 HDAC Inhibitor 68 somatostatin analogues 68 Combination therapy 68 Phase III Trial 68 Pegloticase 68 Myelodysplastic Syndrome MDS 68 Antitumor 68 Epidermal Growth Factor Receptor 68 Lamivudine 68 Factor VIIa 68 metastatic castration resistant 68 fludarabine cyclophosphamide 68 platelet inhibitor 68 histone deacetylase HDAC inhibitor 68 CDK inhibitor 68 Pralatrexate 68 thienopyridines 68 protease inhibitor PI 68 nilotinib Tasigna 68 Phase 2b Study 68 efavirenz EFV 68 Cytarabine 68 IMiDs ® compound 68 Interferon Beta 68 Dalbavancin 68 mycophenolic acid 68 CYP#A# CYP#D# 68 subcutaneously administered 68 microtubule inhibitor 68 Tasimelteon 68 Silodosin 68 Elitek 68 cyclophosphamide methotrexate 68 Campath alemtuzumab 68 alpha 2a 68 Tarceva TM 68 ORENCIA ® 68 interferon alfa 2b 68 topoisomerase II inhibitor 68 Bicalutamide 68 Imatinib 68 Low Dose 68 basiliximab 68 ribavirin RBV 68 temsirolimus Torisel 68 PNP inhibitor 68 liposomal doxorubicin 68 HER2 Positive Breast Cancer 68 Romidepsin 68 Survival Benefit 68 ergot derivatives 68 Revlimid lenalidomide 68 Clevudine 68 IMiDs R 68 Myelodysplastic Syndromes 68 Interferon alpha 67 proteasome inhibitor 67 Levoleucovorin 67 Hypercholesterolemia 67 Lacosamide 67 Protease Inhibitor 67 irbesartan 67 Transdermal Patch 67 plus dexamethasone 67 Anti VEGF 67 Achieves Primary Endpoint 67 oral prodrug 67 Inhaled Corticosteroids 67 pegylated 67 Angiotensin Converting Enzyme 67 azacytidine 67 meropenem 67 Sipuleucel T 67 zidovudine AZT 67 Receptor Antagonists 67 subependymal giant cell 67 Clopidogrel 67 Nexavar ® 67 gastrointestinal stromal tumors 67 APTIVUS 67 vidofludimus 67 Novel Inhibitor 67 Newly Diagnosed Multiple Myeloma 67 sargramostim 67 Galantamine 67 chronic idiopathic thrombocytopenic purpura 67 nicardipine 67 Avastin bevacizumab 67 Intravitreal 67 Phase IIb Trial 67 proteasome inhibitor bortezomib 67 Gastrointestinal Stromal Tumors 67 Intravenous CP 67 Phase 2a Clinical Trial 67 targeted antifolate 67 Relapsing Remitting Multiple Sclerosis 67 3TC lamivudine Epivir 67 Dabigatran etexilate 67 temsirolimus Torisel ® 67 Advanced Melanoma 67 immunosuppressant 67 Myelofibrosis 67 Dacogen decitabine 67 Golimumab 67 Bazedoxifene 67 Investigational Agent 67 Adjunctive 67 Refractory Hodgkin Lymphoma 67 tiotropium bromide 67 dopamine partial agonist 67 XELOX 67 Tasigna nilotinib 67 Carbamazepine 67 FEMALES SHOULD BE ADVISED 67 IN PATIENTS WITH 67 Taxotere docetaxel 67 Pulmonary Arterial Hypertension 67 Node Positive 67 prasugrel Effient 67 pertuzumab 67 polymerase inhibitor 67 Trobalt 67 non nucleoside 67 CHOP chemotherapy 67 Helicobacter pylori eradication 67 Bevacizumab Avastin 67 colony stimulating factor 67 Receptor Agonist 67 alpha 2b 67 R sorafenib tablets 67 APTIVUS R 67 abatacept Orencia 67 Tezampanel 67 long acting bronchodilator 67 idraparinux 67 immunosuppressives 67 tumor lysis syndrome 67 Pixantrone 67 Etoposide 67 Improves Outcomes 67 Anti Tumor 67 Oral Formulation 67 J Am Coll 67 Diabetic Nephropathy 67 Laquinimod 67 Teriflunomide 67 lapatinib Tykerb 67 Fast Track Status 67 gemcitabine chemotherapy 67 immunoconjugate 67 LHRH agonists 67 Methylnaltrexone 67 adriamycin 67 VAPRISOL 67 ZD# [001] 67 Corticosteroids 67 CAELYX 67 Anidulafungin 67 reslizumab 67 imatinib Gleevec 67 Palonosetron 67 Pregabalin 67 sodium glucose cotransporter 67 HuMax CD4 67 FOLFOX6 chemotherapy regimen 67 fluorouracil 67 Mipomersen 67 fulvestrant 67 alkylating agent 67 malignant ascites 67 Chronic Lymphocytic Leukemia 67 Kinase Inhibitor 67 Procoralan 67 novel emulsion formulation 67 daunorubicin 67 nucleoside analogue 67 intranasal formulation 67 Pfizer Sutent 67 potent CYP#A# inhibitors 67 orally bioavailable 67 Orphan Designation 67 vinorelbine tartrate 67 endocrine therapies 67 Inhalation Aerosol 67 pharmacokinetic interactions 67 cetuximab Erbitux 67 Rivaroxaban 67 Patients Receiving 67 Eculizumab 67 tenofovir Viread 67 FUSILEV enhances 67 Tolvaptan 67 chimeric monoclonal antibody 67 lenalidomide Revlimid 67 bendamustine 67 cidofovir 67 Dose Escalation 67 Elagolix 67 idarubicin 67 Ziprasidone 67 EPIVIR 67 Sevelamer 67 pegfilgrastim 67 Tolerability 67 trastuzumab Herceptin 67 carboplatin paclitaxel 67 Ribavirin 67 Ibritumomab Tiuxetan 67 capecitabine Xeloda 67 estramustine 67 Ceflatonin 67 goserelin 67 Known hypersensitivity 67 Lymphocytic 67 Daptomycin 67 Clinical Trial Results 67 abacavir sulfate lamivudine 67 Certolizumab pegol 67 metformin HCl 67 Zoloft sertraline 67 Elvitegravir 67 Metastatic Renal Cell Carcinoma 67 Cisplatin 67 interferon IFN 67 Cardiotoxicity 67 adefovir dipivoxil 67 Linaclotide 67 thienopyridine 67 IL# PE#QQR 67 SERMs 67 Protease Inhibitors 67 Disease Modifying 67 Leukemias 67 Unresectable 67 Gemzar gemcitabine 67 tinidazole 67 Carboplatin 67 Femara letrozole 67 thetreatment 67 HMG CoA reductase inhibitor 67 palifermin 67 Antiangiogenic 67 dacarbazine 67 Mepact 67 Panzem R NCD 67 Panzem R 67 clodronate 67 Xeloda capecitabine 67 immunomodulatory therapy 67 Pivotal Phase III 67 mitoxantrone plus 67 selective agonist 67 HSP# inhibitor 67 voriconazole 67 leukemia AML 67 AZT zidovudine Retrovir 67 Bendamustine 67 Panitumumab 67 rilonacept 67 amprenavir 66 Novel Compound 66 Asacol R 66 paclitaxel poliglumex 66 zoledronate 66 Pafuramidine 66 Oral Spray 66 Vaprisol 66 Combination REOLYSIN R 66 Imatinib mesylate 66 Receptor Antagonist 66 Kinase Inhibitors 66 pancreatic enzyme replacement 66 ULORIC 66 Aviptadil 66 PEGINTRON TM 66 6 mercaptopurine 66 glatiramer 66 eltrombopag 66 FDA APPROVES 66 bortezomib Velcade R 66 interleukin IL -# 66 acetylcholinesterase inhibitor 66 Rotigotine 66 Single Dose 66 CCX# B 66 Filgrastim 66 Relapsing Multiple Sclerosis 66 mesylate 66 Camptosar ® irinotecan 66 potentially hepatotoxic 66 Intravesical 66 Ecallantide 66 Taxotere chemotherapy 66 PEGylated interferon 66 miconazole Lauriad ® 66 See CLINICAL PHARMACOLOGY 66 ribavirin Copegus ® 66 epoprostenol 66 ErbB2 positive 66 cisplatin chemotherapy 66 protein tyrosine phosphatase 1B 66 paclitaxel Taxol R 66 fosbretabulin 66 leukotriene receptor antagonist 66 MyVax R 66 Bafetinib 66 VELCADE melphalan 66 tyrosine kinase inhibitor TKI 66 Halaven 66 anti CD3 66 gemcitabine cisplatin 66 Ramipril 66 Combination Treatment 66 ATACAND 66 Abciximab 66 Desvenlafaxine Succinate 66 heparins 66 Marqibo TM 66 sipuleucel T 66 ACTEMRA TM 66 Inhalation Solution 66 Demonstrates Efficacy 66 relapsed ovarian cancer 66 angiogenesis inhibitor 66 Atypical Hemolytic Uremic Syndrome 66 dose dexamethasone 66 glatiramer acetate 66 selective kinase inhibitor 66 essential thrombocythemia ET 66 agomelatine 66 peginterferon alfa 66 Ofatumumab 66 Certolizumab 66 vinorelbine 66 Relapsed Refractory Multiple Myeloma 66 IgG1 monoclonal antibody 66 sapropterin dihydrochloride 66 clopidogrel Plavix 66 Daclizumab 66 eluting stent 66 relapsing multiple sclerosis 66 dimeglumine 66 tiuxetan 66 AVONEX ® 66 rituximab Rituxan 66 Malignant Melanoma 66 effector function 66 Novantrone 66 Diovan HCT 66 tazobactam 66 Enzyme Replacement Therapy 66 insulin glulisine 66 Fludara 66 DU #b 66 Mirapexin 66 Pegylated interferon 66 clobazam 66 unfractionated heparin UFH 66 Phase 2b Clinical Trial 66 NMIBC 66 Personalized Immunotherapy 66 ABVD 66 Patients Undergoing 66 DORIBAX 66 hypomethylating agents 66 Remicade infliximab 66 Darusentan 66 Gleevec Glivec 66 Advagraf 66 chlorambucil 66 LEUKINE 66 anti angiogenic agent 66 aripiprazole Abilify 66 Investigational Compound 66 calcineurin inhibitor 66 Vicriviroc 66 stage IIIB 66 Vorinostat 66 Hepatocellular Carcinoma 66 Roche Xeloda 66 IFN α 66 QVAR ® 66 humanized anti 66 myelofibrosis polycythemia vera 66 drug zotarolimus 66 Mouse Model 66 deletion 5q 66 PRN FDA Approves 66 soluble tumor necrosis 66 salmeterol fluticasone 66 prucalopride 66 bexarotene 66 Diabetic Neuropathy 66 KRAS mutation 66 Placebo Controlled Trial 66 GlaxoSmithKline Requip 66 Tyrosine Kinase Inhibitor 66 recurrent glioblastoma multiforme 66 Adjunctive Therapy 66 DNA intercalator 66 Paraplatin ® carboplatin 66 Sycrest 66 Polymerase Inhibitor 66 Platinol 66 somatostatin analog 66 Ocrelizumab 66 Molecular Weight Heparin 66 5-FU/LV 66 Sanvar R 66 Elderly Patients 66 hormone LHRH antagonist 66 Aplidin 66 PD LID 66 Sapacitabine 66 complement inhibitor eculizumab 66 mineralocorticoid receptor 66 standard chemotherapy regimen 66 Carbidopa 66 Shows Efficacy 66 Metastatic Prostate Cancer 66 orally administered inhibitor 66 Deforolimus 66 nucleoside reverse transcriptase inhibitor 66 docetaxel Taxotere 66 YONDELIS R 66 flutamide 66 Actemra tocilizumab 66 Trandolapril 66 PDE4 inhibitor 66 antiarrhythmic drug 66 Peginterferon Alfa 2b 66 Hydrochlorothiazide Tablets 66 Vfend 66 Xelox 66 Relapsed 66 SYN# 66 epoetin beta 66 epirubicin 66 bladder carcinoma 66 Teva Provides Update 66 depsipeptide 66 Antiviral Activity 66 Navelbine 66 anti EGFR antibody 66 nadolol 66 PRIALT 66 Copegus ® 66 octreotide acetate 66 Humanized Anti 66 refractory cutaneous T 66 small molecule thrombopoietin 66 Endarterectomy 66 R Saizen R 66 uricase 66 Nebulized 66 monoclonal anti 66 administered concomitantly 66 Cholinesterase Inhibitors 66 Raltegravir 66 benzimidazole 66 dose cytarabine 66 BAL# [002] 66 Hyperlipidemia 66 Blinatumomab 66 adjuvant radiotherapy 66 Orphan Status 66 Neulasta ® 66 erythematosus 66 #/#mg 66 BAY #-# 66 aliskiren amlodipine 66 investigational immunotherapy 66 Thrombin 66 metastatic neuroendocrine tumors 66 Chronic Myeloid Leukemia 66 Zolinza 66 lanreotide 66 galiximab 66 Taxane 66 Vimpat R 66 Phase III Clinical Trial 66 topical gel formulation 66 Microspheres 66 G CSFs 66 Protelos R 66 Perindopril 66 Autologous Stem Cell Transplantation 66 ARIXTRA 66 plasma kallikrein inhibitor 66 CTAP# Capsules 66 romiplostim 66 REVLIMID R 66 JAK Inhibitor 66 Efficacious 66 Atacand 66 T#I [002] 66 Kinoid 66 zonisamide SR 66 Cladribine 66 Randomized Phase 66 Progenitor Cells 66 Insulin Glargine 66 Hydralazine 66 tamoxifen citrate 66 investigational oral inhibitor 66 trastuzumab Herceptin ® 66 Retinoic Acid 66 fludarabine 66 Phase 2a Trial 66 Saquinavir 66 VIDAZA 66 Interferon beta 1b 66 tumor xenograft models 66 Thalomid ® 66 indinavir 66 pain palliation 66 liposomal amphotericin B 66 Dronedarone 66 paricalcitol 66 Emselex 66 Breast Cancer Recurrence 66 Potent Inhibitor 66 Aortic Stenosis 66 interferon alfa 66 Telzir 66 Allergic Rhinitis 66 Camptosar 66 Neupogen ® 66 dihydrochloride 66 orally inhaled 65 NOXAFIL 65 Immunomodulatory 65 Antigen Specific 65 Tumor Response 65 Caelyx 65 Entecavir 65 tigecycline 65 Celgene Revlimid 65 Danazol 65 advanced metastatic renal 65 chemoradiation therapy 65 Letairis ambrisentan 65 idebenone 65 SIR Spheres 65 estrogen receptor antagonist 65 docetaxel Taxotere R 65 Rheumatoid Arthritis Drug 65 myeloid metaplasia 65 SPIRIVA ® 65 Ciclesonide 65 Vitro Activity 65 Controlled Trial 65 pegylated interferon alfa 2a 65 H2 antagonists 65 Investigational Drug 65 Randomized Study 65 Omacetaxine 65 Parathyroid Hormone 65 Hazard Ratio 65 substantially excreted 65 Pharmacokinetic Study 65 metformin XR 65 eribulin mesylate 65 sorafenib Nexavar ® 65 chemoradiotherapy 65 R bisoprolol Euthyrox 65 INCB# [003] 65 terlipressin 65 Vildagliptin 65 Fc fusion protein 65 Prodrug 65 primidone 65 brand ciclesonide HFA 65 invasive candidiasis 65 Pramlintide 65 CYT# potent vascular disrupting 65 oral rivaroxaban 65 Rituxan rituximab 65 Cytoxan ® 65 low dose cytarabine 65 Torisel temsirolimus 65 vincristine doxorubicin 65 Epoetin Alfa 65 Arimidex anastrozole 65 Presents Preclinical Data 65 Teysuno 65 treat benign prostatic 65 Temodar ® 65 Celecoxib 65 Squamous 65 pyrazinamide 65 Vincristine 65 dacarbazine DTIC 65 Bayer Onyx 65 Cimzia TM 65 Systemic Sclerosis 65 Expanded Indication 65 LHRH agonist 65 arginine vasopressin AVP 65 Demonstrated Significant 65 IV Busulfex 65 imipenem 65 imatinib mesylate 65 cutaneous T 65 MTP inhibitor 65 HCV Genotype 65 rFVIIa 65 esomeprazole Nexium 65 terfenadine 65 oblimersen 65 #mg/#mg 65 CsA 65 Pegasys ® 65 tipranavir 65 Icatibant 65 novel VDA molecule 65 antimetabolite 65 rufinamide 65 humanized monoclonal 65 Tekamlo 65 Methotrexate 65 Cremophor 65 Orphan Drug status 65 Protelos 65 Votrient 65 HoFH